Revolutions Medical, a safety medical device and software application company, has secured a 5-year contract to produce 5 million syringes per month of its RevVac 1ml fixed needle safety syringe.
The capacity can be increased to 20 million syringes per month, and shipments will begin by July 2011.
The agreement extends Revolutions Medical’s relationship with Medical Investment Group (MIG), to produce the RevVac 3ml fixed needle safety syringe for delivery in April 2011.
The company is still on schedule to manufacture and produce all of its other RevVac syringe sizes and its RevLok interchangeable needle designs later this year including its new prefilled vacuum safety syringe technology.
Revolutions Medical is also working on its new prefilled vacuum safety syringe technology and should have designs completed this quarter.